Partner Randomised, Phase Ii/Iii Trial To Evaluate The Safety And Efficacy Of The Addition Of Olaparib To Platinum Based Neoadjuvant Chemotherapy In Triple Negative And/Or Germline Brca Mutated Breast Cancer Patients
CANCER RESEARCH(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要